Project - Boost4Health - The Life Sciences Hub of NWE

Description


Description (EN): The NWE life science sector is not exploiting its full potential due to the fragmented market and limited critical mass of its clusters. To grow sustainable new business, innovative NWE life science SMEs need to focus on international markets, but are held back by: Lack of knowledge on internationalisation; Big differences in health care systems, cultures, re-imbursements etc.; Product validation under different regulations; Various studies show that as a result European SMEs often remain small or sometimes prefer to move their business to the less complex US market to grow. In Boost4Health, a partnership of 11 leading life science SME support organisations with strong business networks, will address this market failure by setting up a transnational support programme to help NWE SMEs grow internationally by bringing their life science innovations to European markets. The support programme consists of 3 outputs that will directly help SMEs overcome the above barriers: International business growth strategy programme with coaching and matchmaking provided by support organisations, experts and peer companies; Marketplace and €1,2M micro-funding programme to access international expertise (e.g. market insights, legal support), facilities (e.g. incubator, lab space), partners (e.g. business development support) and financing (e.g. innovative procurement, crowd-funding)
- European product validation network (clinical trial sites, hospitals, home care) for validating life science innovations with users abroad. B4H uses innovative mechanisms where SMEs help other SMEs, building a strong transnational community that lasts beyond the project and positions NWE as a key life science hub. B4H will help 300 SMEs increase their TRL levels through coaching, matchmaking and financial support thus bringing forward the introduction of new life sciences innovations to the international market.
Description: Le secteur des sciences de la vie dans la région de l’ENO est sous-exploité en raison de la fragmentation du marché et de la masse critique limitée de ses clusters. Pour développer de nouvelles activités durables, les PME innovantes dédiées aux sciences de la vie ont besoin de s’internationaliser, mais sont freinées par des obstacles majeurs: >manque de connaissances sur l´internationalisation; >grandes différences entre les systèmes de soin, cultures, remboursement etc.; >validation du produit selon différentes réglementations. Des études montrent que les PME européennes restent souvent petites ou se déplacent aux EU pour se développer. Pour palier cette défaillance du marché, le projet mettra en place un programme de soutien pour aider les PME transnationales à se développer en portant leurs innovations sur les marchés internationaux. Ce programme inclut 3 éléments d’aide aux PME : Programme stratégique de croissance internationale avec coaching et mise en réseau fournis par les organismes de soutien, experts et sociétés comparables. Programme de micro-financement à € 1,2M pour l’accès à une expertise internationale (études de marché, soutien juridique), installations (incubateur, laboratoire), partenaires (soutien au développement) et financement (achats innovants, financement participatif). Réseau européen de validation de produit (sites d´essais cliniques, hôpitaux, soins à domicile) pour valider les innovations auprès d’utilisateurs étrangers. Le projet utilise des mécanismes innovants où des PME s’entraident, créant une communauté transnationale forte et durable et faisant de l’ENO une plaque tournante des sciences de la vie. les partenaires prévoient de mobilisera plus de 10.000 PME de l’ENO dans 12 clusters, soutiendra plus de 150 PME à fort potentiel de développement à l´international, conduisant à un impact en termes de débouchés (<25M€), emploi (>500), patients traités (>100.000).
Description: Der NWE Life Science (LS) Bereich nutzt sein Potenzial wegen Marktfragmentierung und begrenzter kritischer Masse seiner Cluster momentan nicht voll aus. Um machhaltiges Neugeschäft zu entwickeln müssen innovative KMU internationalisieren, aber erhebliche Hindernisse bestehen: Wissensmangel über Internationalisierung. Große Unterschiede bzgl. Gesundheitssysteme, Kulturen, Wiedervergütung usw. Produktvalidierung bei verschiedenen Vorschriften/Studien belegen, dass europäische KMU darum oft klein bleiben oder mit ihrem Unternehmen in die USA ziehen um zu wachsen. Um dieses Marktversagen zu beheben wird das Project ein länderübergreifendes Förderprogramm einrichten. Es wird NWE KMU bei der internationalen Vermarktung ihrer LS-Innovationen unterstützen und ihr internationales Wachstum födern. Das Förderprogramm besteht aus 3 Elementen: Internationales Programm für Unternehmenswachstums-Strategien mit Coaching und Matchmaking durch Unterstützungsorganisationen, Experten und Vergleichsundernehmen/Markt und €1,2 Mikrofinanzierungsprogramm um Zugriff auf internationale Expertise (z.B. Marktkenntnisse), Einrichtungen (z.B. Laborräume), Partner (z.B. Hilfe bei Geschäftsentwicklung) und Finanzierung (z.B. Crowd-funding) zu gewähren/Europäisches Netzwerk zur Produktvalidierung (Prüfzentren, Krankenhäuser, Heimtherapie) um LS-Innovationen mit Nutzern im Ausland zu validieren. Innovative Mechanismen, wobei KMU anderen KMU helfen, können so ein transnationales Gemeinschaftsgefühl hervorrufen und stärken, welches über das Projekt hinaus bestehen wird und NWE als Schlüssel-LS-Hub positioniert. Aufbauend auf Erfahrungswerten, voraussehen die Partner über 10.000 NWE KMU in 12 LS-Cluster erreichen, 150 KMU mit hohem Potenzial aktiv in internationalem Wachstum unterstützen, was Auswirkungen auf Neugeschäft (>€25 Mio.), Arbeitsplätze (>500), behandelte Patienten (>100.000) hat.
Expected Outputs (EN): The partners represent around 5000 life science SMEs, employing 65.000 jobs. Of these SMEs an estimated 10% (500 SMEs) is currently in the phase of proof of concept (TRL 3/4) and will aim to bring products to the market in the next 5 years. This is the baseline for B4H. The aim is to increase the TRL level of this group to 4-6.

Thematic Information


Thematics: Clustering and economic cooperation  SME and entrepreneurship  
Specific Objective: To enhance innovation performance of enterprises throughout NWE regions
Thematic Objective: (1) strengthening research, technological development and innovation by:
Investment Priority: (1b) promoting business investment in R&I, developing links and synergies between enterprises, research and development centres and the higher education sector, in particular promoting investment in product and service development, technology transfer, social innovation, eco-innovation, public service applications, demand stimulation, networking, clusters and open innovation through smart specialisation, and supporting technological and applied research, pilot lines, early product validation actions, advanced manufacturing capabilities and first production, in particular in key enabling technologies and diffusion of general purpose technologies


Project Summary


Project name (EN): Boost4Health - The Life Sciences Hub of NWE
Project acronym: B4H

Period: 2014-2020
Date of latest update: 2019-04-26

Web: http://www.nweurope.eu/

Project start date: 2016-02-25
Project end date: 2020-01-31
Project status: Ongoing

Total budget/expenditure: EUR 4.396.546,27
European Union funding: EUR 2.637.927,76

Project documents

The documents below were published as mentioned in field "Data source" (attached to each document). Keep.eu users are free to use these documents as long as the data source and keep.eu are mentioned.

No outputs available yet.

Partners Data


Lead Partner (EN): Brabant Development Agency
Lead Partner: BOM Business Development & Foreign Investments B.V.
Department: Business Development & Foreign Investments
Address: Goirlese Weg, Tilburg, Netherlands
Website: http://www.bom.nl/
Legal status: public

Department: Business Development Department
Address: Carrer Baldiri Reixac, Torre I planta-1 PCB, Barcelona, Spain
Legal status: private
Website: biocat.cat
Department: Interface Entreprises-Université de Liège (ITF)
Address: Place du 20 Août, Liege, Belgium
Legal status: public
Website: www.ulg.ac.be
Department: Biopeople
Address: Universitetsparken, Copenhagen, Denmark
Legal status: public
Website: www.biopeople.dk
Department: Business Unit: Development & Innovations, Sector: LifeSciences & Health
Address: Laan van Malkenschoten, Apeldoorn, Netherlands
Legal status: public
Website: www.oostnv.com
Department: Economic Development
Address: County Hall, Invicta House 2nd Floor, Maidstone, Kent, United Kingdom
Legal status: public
Website: www.kent.gov.uk
Department: BioRegio STERN
Address: Friedrichstrasse, Stuttgart, Germany
Legal status: private
Website: www.bioregio-stern.de
Department: GM Business Support Ltd
Address: Lee House, Great Bridgewater Street, Manchester, United Kingdom
Legal status: private
Website: http://www.businessgrowthhub.com, http://www.economic-solutions.co.uk/pages/company-information
Department: ID2Santé, European projects
Address: Avenue du Pr Léon Bernard, RENNES Cedex, France
Legal status: private
Website: id2sante.fr
Department: Business Development Department
Address: Avenue Eugène Avinée, Loos-lez-Lille, France
Legal status: private
Website: eurasante.com

Partners Location


  Lead Partner     Project Partner